✦ LIBER ✦

Concomitant chemotherapy and split-course radiation for cure and preservation of speech and swallowing in head and neck cancer

✍ Scribed by Steven M. Hirsch; David D. Caldarelli; James C. Hutchinson Jr.; Lauren D. Holinger; John L. Showel; Samuel G. Taylor IV; Anantha K. Murthy

Book ID: 115043677
Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 420 KB
Volume: 101
Category: Article
ISSN: 0023-852X
DOI: 10.1288/00005537-199106000-00002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of advanced head and neck canc

Treatment of advanced head and neck cancer with concomitant radiation and chemotherapy

✍ Anantha K. Murthy; Samuel G. Taylor IV; John Showel; David D. Caldarelli; James 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 923 KB

Dose, split course radiation and overall

Dose, split course radiation and overall treatment time in head and neck cancer

✍ P.C. Levendag; W.L.J. ban Putten; C.J.M. Hoekstra; M.J.C. ban der Sangen; J. ban 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Concomitant chemotherapy-radiation thera

Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer

✍ Louis B. Harrison; David G. Pfister; Daniel E. Fass; John G. Armstrong; Roy B. S 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 570 KB

Objective assessment of swallowing dysfu

Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer

✍ Avraham Eisbruch; Teresa Lyden; Carol R Bradford; Laura A Dawson; Marc J Haxer; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Pilot trial of concomitant chemotherapy

Pilot trial of concomitant chemotherapy with paclitaxel and split-course radiotherapy for very advanced squamous cell carcinoma of head and neck

✍ Olavo Feher; Sandro J. Martins; Candice A. Lima; João V. Salvajoli; Andrew J. Si 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

## Abstract ## Purpose The combination of chemotherapy and irradiation is considered the standard of care for the treatment of advanced squamous cell carcinoma of head and neck (SCCHN). Paclitaxel has shown a single‐agent activity in SCCHN. Besides, this drug is a promising radiosensitizer for som

Larynx preservation in advanced head and

Larynx preservation in advanced head and neck cancer with chemotherapy and radiation therapy: Implications for the management of the clinically positive neck.

✍ R. Heimann; J. Armstrong; D. Pfister; D. Kraus; M. Zelefsky; J. Shah; R. Spiro; 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 123 KB